Encompass Health Corporation EHC Accrued purchases of property, equipment, and intangible assets
Accrued purchases of property, equipment, and intangible assets at other companies
Other financials
Where this comes from
Reported directly by Encompass Health Corporation in its filing.
Tagged under the XBRL concept ehc:AccruedPurchasesOfPropertyEquipmentAndIntangibleAssets.
The official record: Encompass Health Corporation’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Encompass Health Corporation's accrued purchases of property, equipment, and intangible assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Encompass Health Corporation's accrued purchases of property, equipment, and intangible assets?
- Encompass Health Corporation (EHC) reported accrued purchases of property, equipment, and intangible assets of $27.9M in Q1 2026.
- How has Encompass Health Corporation's accrued purchases of property, equipment, and intangible assets changed year-over-year?
- Encompass Health Corporation's accrued purchases of property, equipment, and intangible assets increased by 381.8% year-over-year, from -$9.9M to $27.9M.
- What is the long-term trend for Encompass Health Corporation's accrued purchases of property, equipment, and intangible assets?
- Over 3 years (2021 to 2024), Encompass Health Corporation's accrued purchases of property, equipment, and intangible assets has grown at a -34.9% compound annual growth rate (CAGR), from $6.9M to $1.9M.
- What does accrued purchases of property, equipment, and intangible assets mean?
- The value of assets purchased on credit that have not yet been paid for in cash.
- How do you interpret accrued purchases of property, equipment, and intangible assets?
- An increase suggests the company is acquiring assets using credit terms, which may impact future cash flow requirements.
- How does accrued purchases of property, equipment, and intangible assets compare across companies?
- Commonly reported in supplemental cash flow disclosures to reconcile capital expenditure figures.